Hilton@PLAY Announces Jess Glynne Concert in London
With nearly a third (32%) of UK professionals admitting that friends and family describe them as ‘workaholics’1, Hilton Worldwide (NYSE: HLT) turns its focus to the Capital in its quest to inspire travellers to reclaim fun with its Hilton@PLAY concert series. Following spectacular performances in Chicago, Dallas and New York, Hilton@PLAY will welcome Jess Glynne to the stage on 22nd October at the soon-to-open Hilton London Bankside, Hilton’s newest hotel in the city.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150930005522/en/
Hilton invites Londoners to exclusive live concert with Jess Glynne on 22nd October at Hilton London Bankside (Photo: Business Wire)
Through the Hilton@PLAY initiative, Hilton and Live Nation are scheduling performances with some of the biggest names in music at Hilton locations throughout the world. To attend the events, members of Hilton HHonors, the loyalty program for Hilton’s 12 distinct hotel brands, are invited to visit HHonors.com/auctions and redeem Hilton HHonors Points.
Geraldine Calpin, global head, marketing and digital, Hilton Worldwide, said, “After hosting three successful Hilton@PLAY concerts at some of our most storied hotels, we’re excited to take a new approach in London, coinciding the concert with the official opening party of Hilton London Bankside. We knew it was time to turn our focus to another city known to work hard, and more importantly, play hard - and with 29 Hilton properties located across the city, London felt like the natural choice. What better way to enjoy the city in all its glory, than by offering an unforgettable performance at our new hotel with chart-topping sensation, Jess Glynne!”
In addition to gaining access to this exclusive concert, Hilton HHonors members can now use HHonors Points on a range of unique experiences throughout Europe, the Middle East, Africa, North America and Asia via the Hilton HHonors auction site. PLAY experiences available now for bid include:
- Access to premium tickets for Live Nation concerts featuring some of the biggest artists at Hilton locations throughout the world
- Ultimate McLaren-Honda VIP race package and a stay at Hilton Abu Dhabi, UAE in November 2015
- Unforgettable golf & elephant experience along with a stay at Conrad Pezula Knysna, South Africa
- Louis Vuitton exhibition package, which includes VIP access and a guided tour along with a night at London Hilton on Park Lane, UK
- Island adventure package including a stay at Hilton Seychelles Labiz Resort & Spa, Silhouette Island, Seychelles
- Unforgettable royal experience at Waldorf Astoria Dubai Palm Jumeirah, Dubai, UAE
Hilton is the Official Hotel Partner of Live Nation and therefore benefits from the fully integrated global music platform including concerts, VIP artist connections, digital media, ticketing, content and performance venues.
About Hilton HHonors
Hilton HHonors is the award-winning guest-loyalty program for Hilton Worldwide’s 12 distinct hotel brands, spanning more than 4,440 hotels, resorts and timeshare properties across 97 countries and territories. Hilton HHonors members who book directly through preferred Hilton channels have access to benefits including free standard Wi-Fi, as well as digital amenities that are available exclusively through the industry-leading Hilton HHonors mobile app, where HHonors members can check-in, choose their room, and access their room using a Digital Key. With 46 million members, HHonors offers hundreds of ways to earn and redeem Points. Members can redeem their Points for free nights, premium merchandise, charitable contributions, or unique events through the HHonors auction site (hhonors.com/auctions), such as exclusive artist experiences and hotel concert events with Live Nation® or a race experience with the McLaren-Honda Formula 1 team. There is no cost to join, and travelers may enroll online by visiting www.HiltonHHonors.com or connect with Hilton HHonors at news.hiltonhhonors.com.
About Hilton Worldwide
Hilton Worldwide (NYSE: HLT) is a leading global hospitality company, spanning the lodging sector from luxury and full-service hotels and resorts to extended-stay suites and focused-service hotels. For 96 years, Hilton Worldwide has been dedicated to continuing its tradition of providing exceptional guest experiences. The company's portfolio of twelve world-class global brands is comprised of more than 4,440 managed, franchised, owned and leased hotels and timeshare properties, with more than 730,000 rooms in 97 countries and territories, including Hilton Hotels & Resorts, Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Curio – A Collection by Hilton, DoubleTree by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The company also manages an award-winning customer loyalty program, Hilton HHonors®. Hilton HHonors members who book directly through preferred Hilton channels have access to benefits including free standard Wi-Fi, as well as digital amenities that are available exclusively through the industry-leading Hilton HHonors app, where HHonors members can check-in, choose their room, and access their room using a Digital Key. Visit news.hiltonworldwide.com for more information and connect with Hilton Worldwide at facebook.com/hiltonworldwide, twitter.com/hiltonworldwide, youtube.com/hiltonworldwide, flickr.com/hiltonworldwide, and linkedin.com/company/hilton-worldwide.
About Jess Glynne
The deep and soulful vocal tone of London-based Jess Glynne became widely known when streams of "My Love," her collaboration with Route 94 -- the house-focused alias of dubstep producer Dream -- appeared online in late 2013. The track went on to hit the U.K. number one spot in March 2014, but not before "Rather Be," featuring another Glynne guest spot -- this time with the inventive chamber music-meets-house act Clean Bandit -- had reached the same chart position that January. "Home," a solo track produced and written by Bless Beats of Big Life Management, appeared online that February. Two further singles became Glynne's first to chart under her own name: both "Right Here" and "Real Love" (the latter featuring Clean Bandit again) hit the British Top Ten before the end of the year. In 2015, Glynne hit number one again as a featured act (on Tinie Tempah's "Not Letting Go"), but she also topped the chart as a solo act with "Hold My Hand." Glynne's debut full-length, I Cry When I Laugh, followed in August of 2015 on Atlantic. In the UK she became the second British female solo artist after Cheryl Cole to have five number one singles.
About Live Nation Entertainment
Live Nation Entertainment (NYSE: LYV) is the world's leading live entertainment company comprised of global market leaders: Ticketmaster, Live Nation Concerts, Live Nation Media & Sponsorship and Artist Nation Management. For additional information, visit www.livenationentertainment.com
1 03/03/2015, by The London Economic
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on